LOGIN
Role of erythropoietin in reducing allogeneic transfusions after joint arthroplasty
September 2014
Role of erythropoietin in reducing allogeneic transfusions after joint arthroplasty
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Preoperative Use of Recombinant Human Erythropoietin Before Total Joint Arthroplasty
J Bone Joint Surg Am. 2003 Sep;85-A(9):1795-800Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
240 patients undergoing arthroplasty of the hip or knee were randomized to preoperatively receive erythropoietin and autologous donation (Group 1), erythropoietin alone (Group 2), or preoperative autologous donation alone (Group 3). Patients were then evaluated postoperatively for allogeneic transfusion requirements, hemoglobin values, and complications or adverse reactions. Patients in Group 1 ha...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.